MetaCap

Cellebrite DI (CLBT) vs Vertex (VERX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Vertex (VERX) has outperformed Cellebrite DI (CLBT) over the past year, losing 12.9% versus a loss of 36.2%. Over five years, CLBT leads with a +24.1% price change compared with -7.1% for VERX. Vertex is the larger company by market cap ($2.80 billion vs $2.71 billion), about 1.0 times the size, while Cellebrite DI is growing revenue faster (+18.6% vs +12.2%).

On valuation, Cellebrite DI trades at a lower forward P/E (16.1x vs 16.6x for Vertex). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 1.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLBT-36.20%VERX-12.94%
+17%-16%-50%
Nov 21, 20251 yearNov 20, 2026
CLBT+16.31%VERX-14.66%
+198%+64%-70%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLBT versus VERX key metrics
MetricCLBTVERX
Share price$10.77$17.23
Market cap$2.71B$2.80B
1-day change-4.86%+0.29%
YTD return-40.27%-13.72%
1-year return-36.20%-12.94%
5-year return+24.08%-7.07%
P/E ratio (TTM)43.08—
Forward P/E16.0916.58
EPS (TTM)$0.25$-0.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$475.68M$748.44M
Revenue growth (YoY)+18.56%+12.25%
Net income (latest FY)$78.33M$7.21M
Gross margin84.20%64.35%
Operating margin13.98%0.31%
Net margin16.47%0.96%
52-week high$19.39$20.82
52-week low$9.58$10.21
Distance from 52-week high-44.46%-17.24%
Analyst consensusstrong_buybuy
Avg. price target upside+43.27%+21.01%
Average volume2.35M1.45M
Shares outstanding251.34M80.11M
Employees1,2852,000
SectorTechnologyTechnology
IndustryComputer Software: Prepackaged SoftwareComputer Software: Prepackaged Software

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • VERX has outperformed CLBT by 23.3 percentage points over the past year.
  • Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 1.0 cents for Vertex.
  • Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs +12.25%).

About Cellebrite DI

CLBT stock →

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Technology · Computer Software: Prepackaged Software · 1,285 employees

About Vertex

VERX stock →

Vertex, Inc., together with its subsidiaries, provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally. The company offers transaction determination; compliance and reporting, including workflow management tools; tax data management and document management solutions; analytics and insights; pre-built integration that includes mapping data fields, and business logic and configurations; industry-specific solutions support certain industries for indirect tax needs, such as retail, communications, and leasing; and technology specific solutions, such as chain flow accelerator and SAP-specific tools.

Technology · Computer Software: Prepackaged Software · 2,000 employees

CLBT vs VERX FAQ

Which is bigger, Cellebrite DI or Vertex?

Vertex (VERX) is larger, with a market capitalization of $2.80B compared with $2.71B for Cellebrite DI (CLBT).

Which stock has performed better over the past year, CLBT or VERX?

VERX returned -12.94% over the past 12 months, compared with -36.20% for CLBT (price return, excluding dividends). Past performance does not predict future results.

Are Cellebrite DI and Vertex in the same industry?

Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.

More comparisons